Health officials set up a program to offer monkeypox vaccinations at large LGBTQIA+ community events in Atlanta, Georgia. They used the JYNNEOS vaccine, which is approved for monkeypox. The goal was to make vaccinations more accessible to people who might be at higher risk.
This was a public health service, not a formal research study. The report does not tell us how many people received the vaccine at these events. It also does not provide any information on whether people experienced side effects or how well the vaccination effort worked.
Because this was not a study, we cannot draw conclusions about the best way to run vaccination programs. The information simply tells us that this outreach effort happened. Readers should see this as a report on a community health service that was provided, not as new evidence about the vaccine itself.